Annu Khajuria serves as a Senior Clinical Studies Analyst at Tunnell Government Services, Inc., where she plays a pivotal role in supporting the Biomedical Advanced Research and Development Authority (BARDA). With her extensive expertise in clinical development and operations, Annu is a Subject Matter Expert...
Annu Khajuria serves as a Senior Clinical Studies Analyst at Tunnell Government Services, Inc., where she plays a pivotal role in supporting the Biomedical Advanced Research and Development Authority (BARDA). With her extensive expertise in clinical development and operations, Annu is a Subject Matter Expert (SME) in the realm of investigational products, particularly within the in vitro diagnostics space. Her deep understanding of clinical diagnostics enables her to identify emerging trends and cutting-edge opportunities while navigating potential challenges in the rapidly evolving landscape of healthcare.
In her current role, Annu is instrumental in the design and execution of clinical trials, leveraging her skills in laboratory management and operations, quality control, and immunochemistry to ensure the integrity and efficacy of investigational products. She collaborates closely with Contract Research Organizations (CROs) to streamline processes and enhance the quality of data generated, ensuring compliance with regulatory standards. Annu’s negotiation skills and emotional intelligence foster effective communication among cross-functional teams, facilitating the successful coordination of complex projects.
Key projects under her leadership have included the development of innovative diagnostic assays and the optimization of laboratory workflows, which have significantly improved turnaround times and accuracy in clinical settings. Annu’s proficiency in hematology, protein chemistry, and electrophoresis further enriches her contributions, positioning her as a vital asset in advancing public health initiatives. Her commitment to scientific excellence and program management continues to drive impactful outcomes in support of BARDA’s mission to enhance national preparedness and response capabilities.
